208 related articles for article (PubMed ID: 28295515)
1. Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy.
Miyazawa H; Yanagi T; Yamaguchi Y; Imafuku K; Kitamura S; Hata H; Uehara J; Ichikawa N; Ohno Y; Yoshida T; Homma S; Kawamura H; Taketomi A; Shimizu H
J Dermatol; 2017 Aug; 44(8):959-962. PubMed ID: 28295515
[TBL] [Abstract][Full Text] [Related]
2. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
3. An unusual presentation of metastatic malignant melanoma causing jejuno-jejunal intussusception: a case report.
Đokić M; Badovinac D; Petrič M; Trotovšek B
J Med Case Rep; 2018 Nov; 12(1):337. PubMed ID: 30419958
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab-induced organizing pneumonia in a melanoma patient.
Sano T; Uhara H; Mikoshiba Y; Kobayashi A; Uchiyama R; Tateishi K; Yamamoto H; Okuyama R
Jpn J Clin Oncol; 2016 Mar; 46(3):270-2. PubMed ID: 26759348
[TBL] [Abstract][Full Text] [Related]
5. Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
Kiyohara Y; Yoshikawa S; Otsuka M; Kondou R; Iizuka A; Nonomura C; Ohshima K; Urakami K; Kusuhara M; Nagashima T; Sugino T; Yamaguchi K; Akiyama Y
J Dermatol; 2017 Oct; 44(10):1156-1159. PubMed ID: 28452169
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report.
Edmondson LA; Smith LV; Mallik A
J Oncol Pharm Pract; 2017 Dec; 23(8):629-634. PubMed ID: 27609337
[TBL] [Abstract][Full Text] [Related]
7. Sarcoid-like reaction and vitiligo occurring after nivolumab therapy in a patient with metastatic melanoma.
Fukuchi K; Hikawa M; Sano Y; Kasuya A; Aoshima M; Tatsuno K; Nakamura Y; Kosugi I; Tokura Y
J Dermatol; 2019 Oct; 46(10):e359-e360. PubMed ID: 30985014
[No Abstract] [Full Text] [Related]
8. Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Kanno H; Ishida K; Yamada W; Nishida T; Takahashi N; Mochizuki K; Mizuno Y; Matsuyama K; Takahashi T; Seishima M
J Infect Chemother; 2017 Nov; 23(11):774-777. PubMed ID: 28527652
[TBL] [Abstract][Full Text] [Related]
9. Metastatic melanoma from an unknown primary site presenting as skin-colored nodules and multiple visceral involvement.
Ghosh SK; Bandyopadhyay D; Barma KD; Basu S; Roy A
Skinmed; 2012; 10(6):396-9. PubMed ID: 23346671
[TBL] [Abstract][Full Text] [Related]
10. A case of multiple metastatic malignant melanoma with the largest lesion in the ileum and no skin lesion.
Suzuki S; Watanabe S; Kato H; Hattori H; Morita A
Kaohsiung J Med Sci; 2012 Dec; 28(12):683-8. PubMed ID: 23217362
[TBL] [Abstract][Full Text] [Related]
11. Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
Pluchart H; Pinsolle J; Cohen J; Ferretti GR; Bedouch P; Giaj Levra M; Toffart AC; Moro-Sibilot D
J Med Case Rep; 2017 Jul; 11(1):183. PubMed ID: 28679408
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma showing a rapid response to nivolumab.
Tsutsumi M; Asai J; Wada M; Takenaka H; Katoh N
Australas J Dermatol; 2016 Feb; 57(1):61-3. PubMed ID: 25854419
[TBL] [Abstract][Full Text] [Related]
13. Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib.
Frieling T; Heise J; Wassilew SW
Dtsch Med Wochenschr; 2009 Jul; 134(28-29):e1-2, 1464-6. PubMed ID: 19572243
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma.
Matsumura N; Ohtsuka M; Kikuchi N; Yamamoto T
Acta Derm Venereol; 2016 Feb; 96(2):259-60. PubMed ID: 26270860
[No Abstract] [Full Text] [Related]
15. Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report.
Uenami T; Hosono Y; Ishijima M; Kanazu M; Akazawa Y; Yano Y; Mori M; Yamaguchi T; Yokota S
Lung Cancer; 2017 Jul; 109():42-44. PubMed ID: 28577948
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
Gambichler T; Strutzmann S; Tannapfel A; Susok L
BMC Cancer; 2017 May; 17(1):327. PubMed ID: 28499411
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant melanoma of the lung: a case report and review of the literature.
Kundranda MN; Clark CT; Chaudhry AA; Chan V; Daw HA
Clin Lung Cancer; 2006 Jan; 7(4):279-81. PubMed ID: 16512984
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.
Ong M; Ibrahim AM; Bourassa-Blanchette S; Canil C; Fairhead T; Knoll G
J Immunother Cancer; 2016; 4():64. PubMed ID: 27777773
[TBL] [Abstract][Full Text] [Related]
19. Complete response to anti-PD-1 nivolumab in massive skin metastasis from melanoma: efficacy and tolerability in an elderly patient.
Sponghini A; Patrucco F; Giorgione R; Farinelli P; Zottarelli F; Rondonotti D; Savoia P
Anticancer Drugs; 2017 Aug; 28(7):808-810. PubMed ID: 28489616
[TBL] [Abstract][Full Text] [Related]
20. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.
Inadomi K; Kumagai H; Arita S; Tsuruta N; Takayoshi K; Mishima K; Ota SI; Tanaka M; Okumura Y; Sagara K; Nio K; Nakano M; Uchi H; Yamamoto H; Ariyama H; Kusaba H; Niiro H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2016 Jul; 95(29):e4283. PubMed ID: 27442668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
